✦ LIBER ✦

P340 Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease – the McGill experience

✍ Scribed by Kopylov, U.; Afif, W.; Cohen, A.; Bitton, A.; Wild, G.; Bessissow, T.; Wyse, J.; Al-Taweel, T.; Szilagy, A.; Seidman, E.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1399 Subcutaneous Ustekinumab for the

✍ Kopylov, Uri; Afif, Waqqas; Cohen, Albert; Bitton, Alain; Wild, Gary; Bessissow, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 349 KB

P-105: Anti-TNF for the prevention of po

✍ Martín-de-Carpi, J.; Pujol, G.; Vila, V.; Pinillos, S.; Tarrado, X.T.; Varea, V. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 54 KB

P531 Effectiveness of anti-TNF agents in

✍ Taxonera, C.; Fernández-Blanco, I.; Barreiro-de Acosta, M.; Bastida, G.; López-S 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

P316 The risk of preoperative anti-TNF-α

✍ Oh, S.H.; Hong, S.N.; Kim, M.J.; Kim, E.R.; Chang, D.K.; Kim, Y.-H. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 173 KB

970 Risk of Lymphoma Associated with Ant

✍ Corey A. Siegel; Sadie M. Marden; Sarah M. Persing; Robin J. Larson; Bruce E. Sa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Sa1110 Comparing the Effectiveness of An

✍ Stidham, Ryan W.; Lee, Terrence; Higgins, Peter D.; Deshpande, Amar R.; Sussman, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB